Legal & General Group
MTCR

Legal & General Group’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Legal & General Group’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-527
Closed -$3K – 3714
2021
Q1 		$3K Hold
527
– – ﹤0.01% 3510
2020
Q4 		$4K Buy
+527
New +$4.83K ﹤0.01% 3455

Other funds holding MTCR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's MTCR Position: Q2 2021 in Review

Legal & General Group sold out of Metacrine, Inc. Common Stock (MTCR) in Q2 2021, closing a stake of 527 shares — an estimated $3K sold.

Legal & General Group first reported a position in MTCR in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q4 2020. 42 funds tracked by Wall St. Rank hold MTCR as of Q2 2021.

  • Legal & General Group reported no remaining Metacrine, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 527 Metacrine, Inc. Common Stock shares in Q2 2021, an estimated $3K.
  • Legal & General Group first reported a position in Metacrine, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Legal & General Group's Metacrine, Inc. Common Stock position peaked at $4K in Q4 2020.
  • 42 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.